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Abstract
Objective
Respiratory diseases, especially infectious ones, are becoming increasingly
representative in the morbidity and mortality patterns of elderly persons. The aim of
the present study was to analyze trends in the mortality by respiratory diseases and to
observe the impact of influenza vaccination on mortality rates.
Methods
The study was carried out between 1980 and 2000. Subjects were elderly persons
living in the State of São Paulo, and mortality data were obtained from the Mortality
Information System of the Brazilian Ministry of Health. This is an ecological time-
series study. We analyzed the time trends of standardized mortality rates by infectious
diseases, according to age group (60-64, 65-69, 70-74, 75-79, and 80+ years) and
sex, using polynomial regression. We estimated confidence intervals for the mean
expected response in the years following the intervention.
Results
Rates increased for both sexes among the elderly population. After the intervention,
we observed a declining trend with respect to mortality indicators. For older males, the
mean rate in the 1980-1998 period was 5.08 deaths per thousand men, with a linear,
non-constant increase of 0.13 per year; in 2000, the rate observed was 4.72 deaths per
thousand men. The mean annual rate among women over 60 years was 3.18 deaths per
thousand women, with a non-constant increase of 0.08 per year; in 2000, the rate
observed was 2.99 deaths per thousand women. There was also a significant reduction
in mortality rates in all age groups.
Conclusions
Data indicate the importance of respiratory diseases among the elderly population and
suggest that specific protection against influenza has a positive effect on the prevention
of mortality due to these diseases.
INTRODUCTION
Respiratory tract diseases, infectious ones espe-
cially, are an important cause of morbidity and mor-
tality among the elderly population worldwide.4,7,10
In Brazil, data from the Sistema de Informações
sobre Mortalidade (Mortality Information System)
indicates the growing importance of hospital admis-
sions and deaths due to respiratory diseases among
the elderly, even considering the ageing of the popu-
lation.6 In 1995, in São Paulo State, the proportional
rate of mortality due to pneumonia among persons
older than 70 years was 9%, with a specific mortality
of 594.03 per 100,000 population. In the 60-70 years
age group, 1,676 deaths were registered, with a pro-
portional mortality of 4.75% and a specific rate of
101.39 per 100,000 population.6,20
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We calculated the annual ratio between standard-
ized male/female rates and evaluated changes in this
relationship throughout the years using simple lin-
ear regression models. We considered p-values above
0.05 as indicative of an absence of change in this
ratio within the studied period.11
Initially, we built scatter plots opposing mortality
rates and calendar years in order to better visualize
the function that might better express the relation-
ship between these variables. Based on the functional
relationship observed, we estimated polynomial re-
gression models, which, in addition to being statisti-
cally powerful, are easy to elaborate and interpret.12,15
During the modeling process, we considered the
rates of mortality due to selected diagnoses as the
dependent variable (Y) and calendar years as the in-
dependent variable (X). The transformation of vari-
able year into variable centralized year (year minus
the midpoint of the time series) was required, since,
in polynomial regression models, the terms in the
equation are often self-correlated.15
As a measure of the model’s precision, we used the
coefficient of determination (r2). We verified adher-
ence to normal distribution using the Kolmogorov-
Smirnov test; all series were normally distributed.
Residual analysis conf irmed the assumed
homocedasticity of the model.11,15
We tested the simple linear regression model
(Υ=β
0
+β1Χ) and then second degree (Υ=β0+β1Χ+β2Χ2),
third degree (Υ=β0+β1Χ+β2Χ2+β3Χ3), and exponential
(Υ=eβ0+β1Χ) models. In light of the statistical similarity
of two of the models, we chose that of lower degree. We
considered as significant trends whose estimated mod-
els obtained p-values below 0.05.11
In these models, β0 is the mean yearly rate, b1 is the
linear effect coefficient (speed), and b
2
 is the quad-
ratic effect coefficient (acceleration). We considered
1989 as the midpoint of the time series.
For some of the age groups, variations in the series
were smoothed using a moving average centered on
three terms. In this process, the smoothed rate of year i
(Y
ai
) corresponds to the arithmetic mean of the coeffi-
cients of the previous year (i-1), of the year itself (i) and
of the following year (i+1):
*Information obtained online from URL: <http://www.datasus.gov.br/cgi/ibge/popmao.htm>
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Influenza epidemics happen more frequently dur-
ing winter. Such epidemics account for a mean 20,000
yearly deaths in the United States.21 Influenza out-
breaks are associated with increases in hospital ad-
missions and deaths, mostly due to complications of
the disease and to chronic subjacent ilnesses.2,3
Vaccination has been the major method for prevent-
ing influenza and its more severe complications. When
vaccine composition coincides with circulating viral
strains, vaccine efficacy can be as high as 70-90% in
healthy adults. Among persons older than 60 years,
however, efficacy falls to the 30-40% range.2,8,10
Even considering the greater physiological and im-
munological susceptibility of elderly persons to in-
fection, influenza vaccination has a positive effect
on the prevention of severe influenza, pneumonia,
and mortality in this risk group.4,8-10,17
The aim of the present study is to analyze trends in
mortality by respiratory diseases among elderly per-
sons and to observe the impact of influenza vaccina-
tion on mortality indicators.
METHODS
This is an ecological time-series study, based on the
mortality records of the Sistema de Informações sobre
Mortalidade do SUS (Mortality Information System of
the Brazilian Unified Healthcare System - SIM/SUS) for
São Paulo State, between the years 1980 and 2000. Es-
timates of the elderly population living in the State were
obtained from the Instituto Brasileiro de Geografia e
Estatística (Brazilian Institute for Geography and Sta-
tistics - IBGE).* Elderly persons were divided into five
age groups: 60 to 64 years, 65 to 69 years, 70 to 74
years, 75 to 79 years, and 80 years and older.
We analyzed diagnoses referring to pneumonias and
influenza (until 1997, ICD-9 classifications 480-483
and 485-487 were used), bronchitis (490 and 491)
and chronic airway obstruction (496). For 1998, ICD-
10 classifications were used (J10 to J15, J18, J22, J40
to J42, and J44). These classifications have been used
by a number of authors attempting to measure the
impact of influenza on the community.7,17,22 We chose
to include chronic obstructive pulmonary disease
(COPD) in light of its intimate relationship with pul-
monary infection among the elderly.22
We calculated standardized mortality rates using
the harmonic mean of the populations in the 1980-
1998 period as a standard population.13
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Based upon the models we estimated us-
ing data from the 1980-98 period, we calcu-
lated confidence intervals for the mean ex-
pected response, i.e., the mortality rates ref-
erent to the two subsequent years (1999 and
2000). In addition to models and confidence
intervals, we also present the rates obtained
after vaccination.
We calculated mortality rates and gener-
ated graphs using Microsoft Excel (Version
7.0 for Windows 95) spreadsheets. We per-
formed trend analyses using SAS (Statistical
Analysis System) Version 8.0 software.
RESULTS
Standardized mortality rates by selected res-
piratory diseases increased among the popula-
tion 60 years and older in São Paulo State be-
tween 1980 and 1998. This was true for both
men and women (Figure 1). Among men, the
mean rate in the period was 5.08 deaths per
thousand men, with a linear non-constant in-
crease of 0.13 per year. Among women, the mean
annual rate was 3.18 deaths per thousand
women, with a non-constant increase of 0.08
per year. The male to female standardized mor-
tality rate ratio did not change with time
(p=0.338). This ratio remained in average 1.55
men for each woman, showing the greater im-
portance of respiratory diseases among men.
An analysis of trends in separate age groups showed
that, for men and women alike (Table 1, Figure 2), the
older the age group, the greater the magnitude of the
annual increment.
The annual linear non-constant increase (β
1
) was
greater among older males. In the 75-79 years age group,
this increase was as much as three times that of the fe-
male population in the same age group. In both sexes,
the population 80 years and older is distinguished by
the magnitude of the mean annual rate (β
0
) (Table 1).
An analysis of mortality rates after the vaccine in-
tervention shows that, in 1999, there was a signifi-
cant reduction in these rates among women in the 70-
74 years age group. In 2000, there was a steep decline
in rates among men in the 70-74 and 80+ years groups,
along with a significant reduction in rates among the
female population in all age groups (Table 2).
For the population over 60 years as a whole, with-
Figure 1 - Standardized mortality rates by selected respiratory diseases
(‰ pop.) among the elderly population, according to sex. Sao Paulo
State, 1980 to 1998.
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Figure 2 - Mortality rates by selected respiratory diseases (‰ pop.) among
the elderly population, according to sex and age group. Sao Paulo State,
1980 to 1998.
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Table 1 - Regression coefficients and statistical significance of trends in mortality rates by selected respiratory diseases,
according to sex and  age groups. São Paulo State, 1980 to  2000.
Sex  β0  β1  β2 p (F) r2
Male
60 a 64a 1.70 0.03 -0.005 <0.001 0.93
65 a 69b 2.96 0.08 -0.007 <0.001 0.87
70 a 74c 5.36 0.14 -0.011 <0.001 0.85
75 a 79d 9.56 0.26 -0.029 <0.001 0.95
80 and oldere 21.29 0.68 -0.039 <0.001 0.84
Female
 60 a 64f 0.79 0.02 -0.001 <0.001 0.82
65 a 69g 1.35 0.04 -0.002 <0.001 0.76
70 a 74h 2.68 0.07 -0.003 <0.001 0.86
75 a 79i 5.05 0.10 -0.007 <0.001 0.74
80 and olderj 14.43 0.43 -0.017 <0.001 0.78
Note: (c, e, f, g, i, j) original series; (a, b, d, h) smoothed series
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out distinction of age group, standardized mean mor-
tality rates by selected respiratory diseases fell within
the expected interval for both male and female popu-
lations in 1999. In 2000, however, there was a signifi-
cant reduction in rates, i.e., rates fell below the lower
limit of the confidence interval (Table 2, Figure 3).
Among the male population, the absence of impact of
vaccination in the years following the intervention was
observed only in the 60-64 years group, whereas the
remaining groups showed a decreasing trend. In the fe-
male population, the decreasing trend is clearer, espe-
cially among the 70-74 and 75-79 age groups (Table 2).
DISCUSSION
Mortality information registries cover the vast ma-
jority (95%) of deaths in São Paulo State, and thus
have sufficient explanatory power for the construc-
tion of satisfactorily reliable mortality indicators.18
Ecological studies of time series are capable of show-
ing the evolution of disease rates in a given geo-
graphically defined population, as well as of evalu-
ating the impact of healthcare interventions, being,
therefore, an adequate design for examining trends
in mortality rates with time.5,11,14
In the present study, we found that the
trends in mortality by selected respiratory
diseases showed a real increase between 1980
and 1998 in São Paulo State, even after con-
trolling for the age composition in the pe-
riod by using standardized rates. However,
the increase in such indicators was asymmet-
ric with respect to sex and age groups, with a
greater annual increase among males and
older groups. Respiratory diseases were con-
firmed as an important cause of death among
the elderly, corroborating the findings of
other authors.6,7,19
Generally speaking, mortality rates by selected res-
piratory diseases usually differ between the sexes in
the age groups studied, but behave similarly in terms
of trends throughout the period.
The peaks in mortality in 1988, 1990, and 1994/
95, seen in Figures 1 and 2, could not be explained
by the present study. Some hypotheses can be offered
for later investigation, including the greater circula-
tion of virulent strains, the circulation of other etio-
logical agents, and climactic factors.
The reduction in mortality rates following vaccine
implementation may be due to reductions in the
number of cases or in the incidence of more severe
cases after vaccination, to the greater sensitivity of
healthcare services in the early diagnosis of severe
pulmonary conditions, or to an improvement in the
specific treatments administered.
When evaluating the impact of influenza vaccina-
tion, one must consider also that virus and bacteria of
different etiologies may be involved in respiratory
conditions leading to the hospitalization and death
of elderly persons,2,3 especially during cold and dry
seasons, this being a worldwide phenomenon.1
Figure 3 - Confidence intervals and standardized mortality rates by
selected respiratory diseases (‰ pop.) among the elderly population,
according to sex. Sao Paulo State, 1980 to 2000.
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Table 2 - Regression models and confidence intervals of mortality rates by selected respiratory diseases, according to sex and
age groups. Sao Paulo State.
Age grups Model Conf. Int. Conf. Int.
Y Est.1999 YObs.1999 Y Est.2000 YObs.2000
Male
60-64 Y = 1.70 + 0.03.X - 0.005.X2 1.42-1.56 1.60 1.34-1.49 1.59
65-69 Y = 2.96 + 0.08.X - 0.007.X2 2.80-3.21 2.84 2.71-3.15 2.73
70-74 Y = 5.36 + 0.14.X - 0.011.X2 5.31-6.05 5.39 5.20-5.99 4.79
75-79 Y = 9.56 + 0.26.X - 0.029.X2 8.88-9.68 10.24 8.50-9.37 8.66
80 and older Y =21.29 + 0.68.X -0.039.X2 22.39-26.16 23.74 22.11-26.18 20.52
60 and older Y = 5.08 + 0.13.X - 0.012.X2 4.88-5.62 5.29 4.74-5.53 4.72
Female
60-64 Y = 0.79 + 0.02.X - 0.001.X2 0.82-0.94 0.85 0.81-0.94 0.80
65-69 Y = 1.35 + 0.04.X - 0.002.X2 1.41-1.67 1.50 1.39-1.68 1.30
70-74 Y = 2.68 + 0.07.X - 0.003.X2 2.87-3.24 2.76 2.85-3.25 2.27
75-79 Y = 5.05 + 0.10.X - 0.007.X2 4.98-5.76 5.30 4.89-5.74 4.45
80 and older Y =14.43 + 0.43.X -0.017.X2 15.64-18.42 16.42 15.60-18.60 14.13
60 and older y = 3.18 + 0.08.X - 0.004.X2 3.34-3.89 3.49 3.31-3.90 2.99
Note: x = (year - 1989)
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Our data show that mortality rates in São Paulo State
were lower in 2000 for both sexes. Repeated yearly
vaccination is associated with greater levels of im-
munological protection and with reduced mortality
compared to the first immunization.1,2 Even consid-
ering the weak immune response of elderly persons
to vaccination, a perspective study conducted in the
Netherlands in 19948 showed that vaccination can
reduce clinical and serological influenza by one-half
in non-institutionalized elderly persons.
Nichol et al16 (1994), in a cohort study carried out
in the United States between 1990 and 1993 with 25
thousand subjects aged 65 years and older, found an
impact on the prevention of hospital admissions due
to pneumonia and influenza (48% to 57%) and to all
acute and chronic respiratory conditions (27% to
39%). In a meta-analysis study, Gross et al9 (1995)
confirmed the reduction in respiratory diseases, hos-
pital admissions, and death among institutionalized
elderly persons following vaccination.
The results of the present study also indicate a re-
duction in mortality by selected respiratory diseases,
varying according to sex and between different age
groups. Nevertheless, a number of factors must be
considered when evaluating the protective effect of
influenza vaccination, including vaccine immuno-
genicity, the agreement between the vaccine’s anti-
gen content and circulating viral strains,8,9 the preva-
lence of chronic diseases in the community, and pre-
vious exposure to the Influenza virus. These factors
vary between the seasons, as well as between differ-
ent regions.
Apart from these considerations, it is likely that the
investments in healthcare directed towards specific
anti-influenza immunization of elderly persons in the
State of São Paulo are having a positive effect on this
populational segment.
In the present study, we sought to draw a general
picture of the behavior of mortality due to respira-
tory tract diseases among elderly persons in the last
decades. Continuous evaluation of this trend in years
to come may provide more consistent evidence of the
impact of successive wide-coverage vaccination cam-
paigns on the Brazilian elderly population.
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